Inactive Instrument
CannaVEST Corp Share Price OTC Bulletin Board
Stocks
US1376531018
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
OTC Bulletin Board
|
||
| - USD | - |
|
| 14/08 | CV Sciences, Inc., Q2 2026 Earnings Call, Aug 13, 2026 | |
| 14/08 | CV Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 28.45L 25.28L 23.6L 21.51L 40.56L 27Cr 40.94L 2.86Cr 1.11Cr 14Cr 1.07Cr 1.05Cr 45Cr | P/E 2024 |
-2.48x | P/E 2025 | -11.8x |
|---|---|---|---|---|---|
| Enterprise Value | 45.63L 40.55L 37.84L 34.49L 65.05L 44Cr 65.66L 4.58Cr 1.77Cr 22Cr 1.71Cr 1.68Cr 72Cr | EV / Sales 2024 |
0.42x | EV / Sales 2025 | 0.95x |
| Free-Float |
78.62% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: CannaVEST Corp
| Manager | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 68 | 31/05/2018 |
Joerg Grasser
DFI | Director of Finance/CFO | 51 | 15/03/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
BRD | Director/Board Member | 68 | 31/05/2018 |
Jamie Corroon
BRD | Director/Board Member | 56 | 21/07/2022 |
William McCorkle
BRD | Director/Board Member | 58 | 21/10/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.61% | -3.43% | +39.40% | +112.31% | 1,02500Cr | |
| -1.02% | -5.60% | +37.67% | +65.02% | 62TCr | |
| +1.11% | -0.58% | +11.10% | +77.28% | 46TCr | |
| +0.34% | -3.01% | +61.21% | +40.71% | 35TCr | |
| -0.95% | -4.05% | +21.60% | +39.37% | 34TCr | |
| -1.46% | -2.89% | +11.84% | +24.60% | 27TCr | |
| -1.35% | -5.43% | -4.69% | +8.40% | 25TCr | |
| -1.04% | -2.79% | +35.52% | +51.34% | 22TCr | |
| -1.87% | -4.10% | +30.92% | +95.33% | 18TCr | |
| Average | -0.23% | -3.15% | +27.17% | +57.15% | 41.31TCr | |
| Weighted average by Cap. | +0.42% | -3.17% | +30.51% | +68.92% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.57Cr 1.4Cr 1.3Cr 1.19Cr 2.24Cr 150.98Cr 2.26Cr 16Cr 6.11Cr 77Cr 5.9Cr 5.77Cr 247.7Cr | 1.38Cr 1.23Cr 1.14Cr 1.04Cr 1.97Cr 132.56Cr 1.98Cr 14Cr 5.36Cr 68Cr 5.18Cr 5.06Cr 217.48Cr |
| Net income | -23.94L -21.27L -19.85L -18.1L -34.13L -23Cr -34.44L -2.4Cr -93.1L -12Cr -89.88L -87.93L -38Cr | -10L -9L -8L -7L -13.66L -9.21Cr -13.78L -96.14L -37.25L -4.71Cr -35.97L -35.19L -15Cr |
| Net Debt | 3L 3L 3L 2L 5L 3.12Cr 5L 32.62L 12.64L 1.6Cr 12.2L 11.94L 5.13Cr | 17.18L 15.26L 14.25L 12.99L 24.49L 17Cr 24.72L 1.72Cr 66.81L 8.44Cr 64.5L 63.1L 27Cr |
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
